fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Desonide

All products: general benefit

PDP-Desonide · DIN 02229323 · 0.05% · Oint

General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
PDP-Desonide · DIN 02229323 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 1997-04-10 Health Canada: Marketed since 2014-08-06 · brand PDP-DESONIDE · ATC D07AB08 DESONIDE · form Ointment · route Topical · ingredients DESONIDE 0.05 %/W/W · company Pendopharm division of pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

PDP-Desonide: Formulary list price $0.29 per unit (the source does not state the unit; exact figure $0.2853). What the ministry pays, not the patient.

Ministry pays: $0.2853 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02229323)

Source record
DIN 02229323: PDP-Desonide Raw flags: sec3=Y Item: 840600045; group id 842; item number 2052; lccId None; manufacturer id PEN Source form: Oint; strength: 0.05% Recorded listing: General benefit Source prices (unrounded): $0.2853; ministry $0.2853 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02229323 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43537
Interchangeable products
Tridesilon · DIN 02154870 · not recorded
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (D07A, D07AB): coverage varies; not interchangeable

  • Triamcinolone acetonide (Kenalog): general benefit, not a benefit
  • Amcinonide (Cyclocort): general benefit, not a benefit
  • Beclomethasone dipropionate (Propaderm): general benefit
  • Betamethasone dipropionate (Diprosone): general benefit
  • Betamethasone dipropionate in a base containing propylene glycol (Diprolene): general benefit
  • Betamethasone dipropionate in propylene glycol base (Diprolene Glycol): general benefit

8 more in the class list below

Other drugs in the same formulary class (84:06 Anti-Inflammatory) and how they are covered

Matched class: 84:06 Anti-Inflammatory

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BECLOMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE IN A BASE CONTAINING PROPYLENE GLYCOL, BETAMETHASONE DIPROPIONATE IN PROPYLENE GLYCOL BASE, CALCIPOTRIOL & BETAMETHASONE DIPROPIONATE, HALOBETASOL PROPIONATE, MOMETASONE FUROATE Some products covered without a code (check the product listing): AMCINONIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE VALERATE, CLOBETASOL PROPIONATE, FLUOCINONIDE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE VALERATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE 0.1% IN ORABASE 84:06 Anti-Inflammatory

TRIAMCINOLONE ACETONIDE

· 5 products · Listed, not a benefit (3), General benefit (2) · strengths: 0.1% · Cr, Oint

AMCINONIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.1% · Cr

BECLOMETHASONE DIPROPIONATE

· 2 products · General benefit · strengths: 0.025% · Cr, Oint

BETAMETHASONE DIPROPIONATE

· 6 products · General benefit (5), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1) · strengths: 0.05% · Cr, Lot, Oint

BETAMETHASONE DIPROPIONATE IN A BASE CONTAINING PROPYLENE GLYCOL

· 2 products · General benefit · strengths: 0.05% · Oint

BETAMETHASONE DIPROPIONATE IN PROPYLENE GLYCOL BASE

· 2 products · General benefit · strengths: 0.05% · Cr

BETAMETHASONE VALERATE

· 19 products · Listed, not a benefit (7), General benefit (12) · strengths: 0.05%, 0.1% · Cr, Lot, Oint, Scalp Lot

CLOBETASOL PROPIONATE

· 20 products · General benefit (11), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 0.05%, 0.05% w/w · Cr, Oint, Scalp Lot, Top Shampoo, Top Sol Sp

FLUOCINONIDE

· 8 products · General benefit (4), Listed, not a benefit (4) · strengths: 0.05% · Cr, Emol Cr, Gel, Oint

HALOBETASOL PROPIONATE

· 1 products · General benefit · strengths: 0.01% w/w · Lot

HYDROCORTISONE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.5%, 1% · Oint

HYDROCORTISONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Cr Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:06 and 5 more
Full class listing Related classes: 84:04 Anti-Infectives, 84:28 Keratolytic Agents, 84:36 Miscellaneous Skin and Mucous Membrane Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE pdp-DESONIDE (desonide) 0.05% topical preparations are intended for use in the management of acute or chronic dermatoses. They have been demonstrated to have anti-inflammatory activity when used topically in:  Atopic Dermatitis  Contact Dermatitis (including Poison Ivy and Venenata)  Psoriasis  Eczema (including Nummular Eczema)  Neurodermatitis  Seborrheic Dermatitis  Lichen Simplex Chronicus (Lichen Planus)  Dyshidrosis  Acute Solar Dermatitis (Sunburn)  Statis Dermatitis 3 https://pdf.hres.ca/dpd_pm/00060564.PDF PM date: March 26, 2021 Source product: PDP-DESONIDE; DIN 02229315; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.